- Home
- ERAS vs DJCO Comparison
ERAS vs DJCO Comparison
Compare ERAS & DJCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ERAS | DJCO |
|---|---|---|
| Founded | 2018 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 706.2M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ERAS | DJCO |
|---|---|---|
| Price | $13.56 | $490.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $11.38 | N/A |
| AVG Volume (30 Days) | ★ 3.7M | 90.5K |
| Earning Date | 03-12-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 36.23 | ★ 43.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,384,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.01 | $348.63 |
| 52 Week High | $16.14 | $674.75 |
Technical Indicators
Market Signals| Indicator | ERAS | DJCO |
|---|---|---|
| Relative Strength Index (RSI) | 52.50 | 42.78 |
| Support Level | $1.50 | $481.78 |
| Resistance Level | $16.14 | $495.51 |
| Average True Range (ATR) | 1.03 | 34.45 |
| MACD | -0.38 | -1.94 |
| Stochastic Oscillator | 20.16 | 32.01 |
Price Performance
Historical ComparisonAbout ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About DJCO Daily Journal Corp. (S.C.)
Daily Journal Corp publishes newspapers and websites covering California and Arizona and produces several specialized information services. The company operates in two segments: Traditional business and Journal Technologies which includes Journal Technologies, Inc. and Journal Technologies (Canada) Inc. It also serves as a newspaper representative specializing in public notice advertising. The majority of revenue is generated from the Traditional segment.